ACUTE ISCHEMIC STROKE (AIS)

This study is testing a medical device called the Penumbra System in 200 adults aged 18-75 who have had a severe stroke caused by a blocked artery. The device is used to remove the clot and restore blood flow to the brain. The main goal is to see how well and how safely the devic…

This trial tests whether doing brain scans and clot-removal procedures in the same room speeds up treatment for severe strokes. About 390 patients with suspected large-vessel blockages will be randomly assigned to either the usual two-room process or a one-room approach. The goal…

This study tests whether stem cells from donated umbilical cords can improve recovery after a recent stroke. About 60 adults who had a stroke within the last 72 hours will receive either one or two infusions of these cells or a placebo. The goal is to see if the treatment helps r…

This phase 3 trial is testing two different doses of the clot-busting drug tenecteplase in 4,000 people who have had an acute ischemic stroke. The goal is to find out which dose works best and is safest, especially for patients who have taken blood thinners or are undergoing a pr…

This study tests whether galantamine, a compound from the Lycoris aurea plant, can improve recovery in people who have had an acute ischemic stroke. The trial will involve 66 adults who receive either galantamine injections plus standard care, or standard care alone, for 10 days.…

This study is for people who have had a very large stroke caused by a blocked artery in the brain. Doctors want to see if a procedure to remove the clot (called thrombectomy) can help them recover better. The study will track 1000 patients for 90 days to measure their level of di…

This study compares two types of catheters used during mechanical thrombectomy for acute ischemic stroke: a balloon guide catheter and a conventional guide catheter. Researchers want to see if one approach restores blood flow faster and leads to better outcomes. About 100 adults …